يعرض 1 - 10 نتائج من 18 نتيجة بحث عن '"Ercc1 gene"', وقت الاستعلام: 2.11s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية

    المساهمون: Работа выполнена при поддержке гранта РФФИ №18-29-09087

    المصدر: Siberian journal of oncology; Том 20, № 1 (2021); 105-114 ; Сибирский онкологический журнал; Том 20, № 1 (2021); 105-114 ; 2312-3168 ; 1814-4861 ; 10.21294/1814-4861-2021-20-1

    وصف الملف: application/pdf

    العلاقة: https://www.siboncoj.ru/jour/article/view/1697/833Test; Ostrom Q.T., Gittleman H., Truitt G., Boscia A., Kruchko C., Barnholtz-Sloan J.S. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 20112015. Neuro Oncol. 2018 Oct 1; 20(suppl_4): iv1iv86. doi:10.1093/neuonc/noy131.; Gill P., Litzow M., Buckner J., Arndt C., Moynihan T., Christianson T., Ansell S., Galanis E. High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system. Cancer. 2008 Apr 15; 112(8): 1805–11. doi:10.1002/cncr.23362.; Nishihara H., Ozaki Y., Ito T., Yoshinaga T., Tabu K., Tanino M., Nagashima K., Tanaka S. A case of cerebral ganglioneuronal tumor in the parietal lobe of an adult. Brain Tumor Pathol. 2008; 25(1): 45–9. doi:10.1007/s10014-008-0229-5.; Mellai M., Monzeglio O., Piazzi A., Caldera V., Annovazzi L., Cassoni P., Valente G., Cordera S., Mocellini C., Schiffer D. MGMT promoter hypermethylation and its associations with genetic alterations in a series of 350 brain tumors. J Neurooncol. 2012 May; 107(3): 617–31. doi:10.1007/s11060-011-0787-y.; O'Reilly S.M., Newlands E.S., Glaser M.G., Brampton M., Rice-Edwards J.M., Illingworth R.D., Richards P.G., Kennard C., Colquhoun I.R., Lewis P. Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours. Eur J Cancer. 1993; 29A(7): 940–2. doi:10.1016/s0959-8049(05)80198-4.; Durando X., Thivat E., Gilliot O., Irthum B., Verrelle P., Vincent C., Bay J.O. Temozolomide treatment of an adult with a relapsing medulloblastoma. Cancer Invest. 2007 Sep; 25(6): 470–5. doi:10.1080/07357900701518164.; Poelen J., Bernsen H.J., Prick M.J. Metastatic medulloblastoma in an adult; treatment with temozolomide. Acta Neurol Belg. 2007 Jun; 107(2): 51–4.; Metzger R., Leichman C.G., Danenberg K.D., Danenberg P.V., Lenz H.J., Hayashi K., Groshen S., Salonga D., Cohen H., Laine L., Crookes P., Silberman H., Baranda J., Konda B., Leichman L. ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy. J Clin Oncol. 1998 Jan; 16(1): 309–16. doi:10.1200/JCO.1998.16.1.309.; Rosell R., Cobo M., Isla D., Sanchez J.M., Taron M., Altavilla G., Santarpia M., Moran T., Catot S., Etxaniz O. Applications of genomics in NSCLC. Lung Cancer. 2005 Dec; 50 Suppl 2: S33–40.; Matsubara J., Nishina T., Yamada Y., Moriwaki T., Shimoda T., Kajiwara T., Nakajima T.E., Kato K., Hamaguchi T., Shimada Y., Okayama Y., Oka T., Shirao K. Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer. Br J Cancer. 2008 Feb 26; 98(4): 832–9. doi:10.1038/sj.bjc.6604211.; Liu Z.G., Chen H.Y., Cheng J.J., Chen Z.P., Li X.N., Xia Y.F. Relationship between methylation status of ERCC1 promoter and radiosensitivity in glioma cell lines. Cell Biol Int. 2009; 33(10): 1111–7. doi:10.1016/j.cellbi.2009.07.004.; Chen H.Y., Shao C.J., Chen F.R., Kwan A.L., Chen Z.P. Role of ERCC1 promoter hypermethylation in drug resistance to cisplatin in human gliomas. Int J Cancer. 2010 Apr 15; 126(8): 1944–1954. doi:10.1002/ijc.24772.; Мацко Д.Е. Нейрохирургическая патология. СПб., 2015. 424 с.; Улитина А.Ю., Мацко Д.Е., Олюшин В.Е. Нейроэпителиальные опухоли головного мозга. СПб., 2014. 446 с.; Burger P.C., Scheithauer B.W. Tumors of the Central Nervous System. Washington: American Registry of Pathology, 2007. 596 p.; Sturm D., Orr B.A., Toprak U.H., Hovestadt V., Jones D.T.W., Capper D., Sill M., Buchhalter I., Northcott P.A., Leis I., Ryzhova M., Koelsche C., Pfaff E., Allen S.J., Balasubramanian G., Worst B.C., Pajtler K.W., Brabetz S., Johann P.D., Sahm F., Reimand J., Mackay A., Carvalho D.M., Remke M., Phillips J.J., Perry A., Cowdrey C., Drissi R., Fouladi M., Giangaspero F., Łastowska M., Grajkowska W, Scheurlen W., Pietsch T., Hagel C., Gojo J., Lötsch D., Berger W., Slavc I., Haberler C., Jouvet A., Holm S., Hofer S., Prinz M., Keohane C., Fried I., Mawrin C., Scheie D., Mobley B.C., Schniederjan M.J., Santi M., Buccoliero A.M., Dahiya S., Kramm C.M., von Bueren A.O., von Hoff K., Rutkowski S., Herold-Mende C., Frühwald M.C., Milde T., Hasselblatt M., Wesseling P., Rößler J., Schüller U., Ebinger M., Schittenhelm J., Frank S., Grobholz R., Vajtai I., Hans V., Schneppenheim R., Zitterbart K., Collins V.P., Aronica E., Varlet P., Puget S., Dufour C., Grill J., Figarella-Branger D., Wolter M., Schuhmann M.U., Shalaby T., Grotzer M., van Meter T., Monoranu C.M., Felsberg J., Reifenberger G., Snuderl M., Forrester L.A., Koster J., Versteeg R., Volckmann R., van Sluis P., Wolf S., Mikkelsen T., Gajjar A. Aldape K., Moore A.S., Taylor M.D., Jones C., Jabado N., Karajannis M.A., Eils R., Schlesner M., Lichter P., von Deimling A., Pfister S.M., Ellison D.W., Korshunov A., Kool M. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs. Cell. 2016; 164(5): 1060–1072. doi:10.1016/j.cell.2016.01.015.; Oh J., Bilbao J.M., Tsao M.N., Fazl M., Guiot M.C., Del Maestro R.F., Perry J.R. Recurrent PNET with MGMT methylation responds to temozolomide. Can J Neurol Sci. 2009 Sep; 36(5): 654–7. doi:10.1017/s0317167100008209.; Yamada A., Moritake H., Shimonodan H., Yokogami K., Takeshima H., Marutsuka K., Nunoi H. Efficacy of temozolomide in a central nervous system relapse of neuroblastoma with O 6 -methylguanine methyltransferase (MGMT) promoter methylation. J Pediatr Hematol Oncol. 2013 Jan; 35(1): e38–41. doi:10.1097/MPH.0b013e318270a361.; Rao R.D., Robins H.I., Mehta M.P. Late recurrence of a primitive neuro-ectodermal tumor. Oncology. 2001; 61(3): 189–91. doi:10.1159/000055373.; Terheggen F., Troost D., Majoie C.B., Leenstra S., Richel D.J. Local recurrence and distant metastasis of supratentorial primitive neuroectodermal tumor in an adult patient successfully treated with intensive induction chemotherapy and maintenance temozolomide. J Neurooncol. 2007 Mar; 82(1): 113–6. doi:10.1007/s11060-006-9249-3.; Beckmann P.J., Larson J.D., Larsson A.T., Ostergaard J.P., Wagner S., Rahrmann E.P., Shamsan G.A., Otto G.M., Williams R.L., Wang J., Lee C., Tschida B.R., Das P., Dubuc A.M., Moriarity B.S., Picard D., Wu X., Rodriguez F.J., Rosemarie Q., Krebs R.D., Molan A.M., Demer A.M., Frees M.M., Rizzardi A.E., Schmechel S.C., Eberhart C.G., Jenkins R.B., Wechsler-Reya R.J., Odde D.J., Huang A., Taylor M.D., Sarver A.L., Largaespada D.A. Sleeping Beauty Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal Tumors. Cancer Res. 2019 Mar 1; 79(5): 905–917. doi:10.1158/0008-5472.CAN-18-1261.; https://www.siboncoj.ru/jour/article/view/1697Test

  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
  6. 6

    المساهمون: Molecular Genetics, Cell biology, Pathology, Sepe, Sara, Milanese, Chiara, Gabriels, Sylvia, Derks, Kasper W. J., Payan Gomez, Cesar, van IJcken, Wilfred F. J., Rijksen, Yvonne M. A., Nigg, Alex L., Moreno, Sandra, Cerri, Silvia, Blandini, Fabio, Hoeijmakers, Jan H. J., Mastroberardino, Pier G.

    المصدر: Cell Reports, Vol 15, Iss 9, Pp 1866-1875 (2016)
    Cell Reports, 15(9), 1866-1875. Cell Press
    Cell Reports
    Ahmad, A., Robinson, A.R., Duensing, A., van Drunen, E., Beverloo, H.B., Weisberg, D.B., Hasty, P., Niedernhofer, L.J., ERCC1-XPF endonuclease facilitates DNA double-strand break repair (2008) Mol. Cell. Biol., 28, pp. 5082-5092
    Repositorio EdocUR-U. Rosario
    Universidad del Rosario
    instacron:Universidad del Rosario

    مصطلحات موضوعية: Genetics and Molecular Biology (all), 0301 basic medicine, Gene Mutation, Aging, Parkinson's disease, Excision Repair Cross Complementing Protein 1, Mouse, Protein Homeostasis, DNA Repair, Protein Expression, Enfermedad de parkinson, Gene Expression, Gene mutation, Biochemistry, Protein Phosphorylation, Edad adulta, Mice, chemistry.chemical_compound, Pathology, Down Regulation, lcsh:QH301-705.5, Neuropathology, Vejez, Cre Recombinase, Genetics, MPTP, Oxidation Reduction State, Parkinson Disease, 3. Good health, DNA-Binding Proteins, Animals, Corpus Striatum, Dopaminergic Neurons, Endonucleases, Fibroblasts, Humans, Biochemistry, Genetics and Molecular Biology (all), Dna Damage, Ultrastructure, Priority Journal, Fibroblast, Histone H2Ax Gamma, Autonomic Innervation, Human, Dopaminergic Nerve Cell, Disease Association, DNA repair, DNA damage, Skin Fibroblast, Dna-Binding Proteins, Biology, Article, General Biochemistry, Genetics and Molecular Biology, Rna Sequence, Dna Repair, Enzyme Activity, Unclassified Drug, 03 medical and health sciences, SDG 3 - Good Health and Well-being, Upregulation, Report, medicine, Controlled Study, Dopaminergic System, Endonuclease, Double Stranded Dna Break, Human Cell, Alpha-synuclein, Histone H2Ax, Excision Repair, Animal, Ercc1 Gene, Alpha Synuclein, Animal Experiment, Nonhuman, medicine.disease, Dna Binding Protein, Enfermedades, Ercc1 Protein, Metabolism, 030104 developmental biology, lcsh:Biology (General), chemistry, Mitochondrial Respiration, Cancer research, Animal Model, ERCC1, Nucleotide excision repair

    وصف الملف: application/pdf

  7. 7

    المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961], Karavasilis, V. [0000-0002-5806-9399]

    المصدر: Pharmacogenomics

    مصطلحات موضوعية: Male, Oncology, Genetic association studies, Messenger rna, medicine.medical_treatment, Kaplan-Meier Estimate, Biomarkers, Pharmacological, Carboplatin, chemistry.chemical_compound, Cancer specific survival, Genotype, Urothelial cancer, Treatment outcome, Single nucleotide, Middle aged, Survival time, Single-nucleotide polymorphism, Platinum derivative, Genetic analysis, Homozygote, Urogenital tract cancer, Human ercc1 gene, Middle Aged, Excision repair cross complementing protein 1, Polymerase chain reaction, Urologic neoplasms, DNA-Binding Proteins, Treatment Outcome, Molecular Medicine, Female, Cancer chemotherapy, Restriction fragment length polymorphism, Human, medicine.drug, Adult, Heterozygote, Urologic Neoplasms, medicine.medical_specialty, Disease-free survival, Drug response, Major clinical study, Biology, Vinblastine, Polymorphism, Single Nucleotide, Article, Disease-Free Survival, Dose densification, Advanced cancer, Internal medicine, Genetics, medicine, Humans, Polymorphism, Genotyping, Genetic Association Studies, Aged, Neoplasm Staging, Platinum, Gene amplification, Pharmacology, Cisplatin, Cancer prognosis, Chemotherapy, Pharmacological, Dna, Kaplan-meier estimate, Endonucleases, Gemcitabine, Gene frequency, Dna-binding proteins, Single nucleotide polymorphism, Nucleotide excision repair, Methotrexate, chemistry, Doxorubicin, Ercc1 gene, Pharmacogenetics, Neoplasm staging, Genetic association, Cancer patient, Progression free survival, ERCC1, Biomarkers

  8. 8
    دورية أكاديمية
  9. 9
  10. 10